| Page 1180 | Kisaco Research
 

Kimberly Doggett

Senior Director, Clinical Trial Diversity
BeiGene

Kimberly Doggett

Senior Director, Clinical Trial Diversity
BeiGene

Kimberly Doggett

Senior Director, Clinical Trial Diversity
BeiGene
 

Martina Tyreus Hufnal

Principal
Fish & Richardson

Martina is a principal in Fish & Richardson’s Delaware office. Her practice focuses on intellectual property litigation and covers a wide range of technologies. Martina has extensive experience in the pharmaceutical field, including Hatch-Waxman litigation, as well as chemical and software cases. Martina’s experience covers all aspects of pre-litigation diligence and litigation, including case assessment, electronic document collection and production, managing teams handling fact and expert discovery, settlement strategy, and trial work.

Martina Tyreus Hufnal

Principal
Fish & Richardson

Martina Tyreus Hufnal

Principal
Fish & Richardson

Martina is a principal in Fish & Richardson’s Delaware office. Her practice focuses on intellectual property litigation and covers a wide range of technologies. Martina has extensive experience in the pharmaceutical field, including Hatch-Waxman litigation, as well as chemical and software cases. Martina’s experience covers all aspects of pre-litigation diligence and litigation, including case assessment, electronic document collection and production, managing teams handling fact and expert discovery, settlement strategy, and trial work. She offers a diverse perspective to clients on litigation impact on business as well as implications of post-grant proceedings. Clients describe her as “outstanding lead counsel” who is “known for her prowess in post-grant proceedings and great in Hatch-Waxman actions.”

 

Tesheia Johnson

Chief Operating Officer
Yale

Tesheia Johnson

Chief Operating Officer
Yale

Tesheia Johnson

Chief Operating Officer
Yale
 

Maria Vassileva

Senior Vice President of Strategy
The Arthritis Foundation

Maria Vassileva

Senior Vice President of Strategy
The Arthritis Foundation

Maria Vassileva

Senior Vice President of Strategy
The Arthritis Foundation
 

Melodie Narain-Blackwell

Founder
Color of Chron’s and Chronic Illness

Melodie Narain-Blackwell

Founder
Color of Chron’s and Chronic Illness

Melodie Narain-Blackwell

Founder
Color of Chron’s and Chronic Illness
 

Naikia Atkinson

Director, US Clinical Trial Diversity and Inclusion
Sanofi

Naikia Atkinson

Director, US Clinical Trial Diversity and Inclusion
Sanofi

Naikia Atkinson

Director, US Clinical Trial Diversity and Inclusion
Sanofi
Megan Murphy Interview-PCOS
 

Celia Bisbach

Research Scientist
Promega

Celia received her Ph.D. in Biochemistry from the University of Washington studying energy metabolism in ocular tissues. She joined Promega in early 2022 and is focused on advancing strategies for targeted protein degradation including developing tool compounds for studying membrane protein degradation as well as approaches to identify new E3 ligases capable of degrading various target proteins.

Celia Bisbach

Research Scientist
Promega

Celia Bisbach

Research Scientist
Promega

Celia received her Ph.D. in Biochemistry from the University of Washington studying energy metabolism in ocular tissues. She joined Promega in early 2022 and is focused on advancing strategies for targeted protein degradation including developing tool compounds for studying membrane protein degradation as well as approaches to identify new E3 ligases capable of degrading various target proteins.

 

Jason Moore

Founder & CEO
Spren

Jason Moore

Founder & CEO
Spren

Jason Moore

Founder & CEO
Spren